Fox Christine — SEC Form 4 filings
SEC reporting owner CIK 1998173. 9 Form 4 filings on record with FilingPulse; latest filed 2026-05-04.
Transaction summary — filings shown
Covers all 9 filings on record, filed 2024-03-05 to 2026-05-04. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 8 legs across 7 filings — 122,078 shares, $3,174,491 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 13.
- Largest priced transaction: sale of 30,000 shares @ $25.11 ($753,321) in TEVA PHARMACEUTICAL INDUSTRIES LTD, filed 2025-11-18.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | EVP, U.S. Commercial | 9 | — | 8 legs · 122,078 sh · $3,174,491 | 13 |
Form 4 filings — Fox Christine
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-05-04 | 4 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Sale (S): 21,258 @ $35.31 | EDGAR |
| 2026-03-09 | 4 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Option exercise (M): 17,819 · Sale (S): 7,924 @ $31.67 · Option exercise (M): 17,819 (derivative) @ $0 | EDGAR |
| 2026-03-06 | 4 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Option exercise (M): 20,461 · Sale (S): 9,098 @ $32.46 · Option exercise (M): 20,461 (derivative) @ $0 · Grant/award (A): 50,643 (derivative) @ $0 | EDGAR |
| 2025-11-24 | 4 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Option exercise (M): 63,492 · Sale (S): 28,229 @ $24.78 · Option exercise (M): 63,492 (derivative) @ $0 | EDGAR |
| 2025-11-18 | 4 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Sale (S): 30,000 @ $25.11 | EDGAR |
| 2025-03-07 | 4 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Grant/award (A): 71,278 (derivative) @ $0 | EDGAR |
| 2025-03-06 | 4 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Option exercise (M): 20,461 · Sale (S): 4,034 @ $15.73 · Sale (S): 2,147 @ $15.91 · Option exercise (M): 20,461 (derivative) @ $0 | EDGAR |
| 2024-11-21 | 4 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Option exercise (M): 63,492 · Sale (S): 19,388 @ $16.87 · Option exercise (M): 63,492 (derivative) @ $0 | EDGAR |
| 2024-03-05 | 4 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Grant/award (A): 81,845 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1998173 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →